CHARMI PATEL: Open Payments
NPI 1518364512 · PLACENTIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 84 payments from 14 companies in 2025. Trend: 2023 $496 · 2024 $1,673 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 12 | $191 |
| Verrica Pharmaceuticals Inc. | 25 | $188 |
| Incyte Corporation | 20 | $183 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| GENZYME CORPORATION | 2 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $51 |
| Lilly USA, LLC | 2 | $49 |
| UCB, Inc. | 2 | $48 |
| ABBVIE INC. | 3 | $45 |
Products named: Zoryve, YCANTH, OPZELURA, DUPIXENT, COSENTYX, Winlevi, Bimzelx, TREMFYA.
Industry payments across CA — which companies pay providers there.
